BMP4 has been shown to promote prostate tumor growth in bone by stimulating osteogenesis [50] and, specifically, to stimulate endothelial to osteoblast conversion leading to osteoblastic bone formation in prostate cancer patients [51]. This evidence concerns the gene BMP4 and prostate carcinoma.